Periorbital edema secondary to imatinib mesylate

Abstract

Imatinib mesylate (Gleevec((R))) is a well-established pharmacologic treatment for all phases of chronic myeloid leukemia and for advanced gastrointestinal stromal tumors (GISTs). Edema-related side effects are relatively common in imatinib therapy with the periocular skin representing one of the most common sites for localized edema. While the adverse… (More)

Topics

3 Figures and Tables

Cite this paper

@inproceedings{McClelland2010PeriorbitalES, title={Periorbital edema secondary to imatinib mesylate}, author={Collin M. McClelland and George J. Harocopos and Philip L Custer}, booktitle={Clinical ophthalmology}, year={2010} }